170 related articles for article (PubMed ID: 22639238)
1. Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.
Zhang Z; Yao J
AAPS PharmSciTech; 2012 Sep; 13(3):802-10. PubMed ID: 22639238
[TBL] [Abstract][Full Text] [Related]
2. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
[TBL] [Abstract][Full Text] [Related]
3. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome.
Wang X; Li Y; Wang D; Wang X; Yuan W; Zhao W; Xia G
Pharm Dev Technol; 2021 Jan; 26(1):110-118. PubMed ID: 33104406
[TBL] [Abstract][Full Text] [Related]
5. Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11.
Sadzuka Y; Hirotsu S; Hirota S
Cancer Lett; 1998 May; 127(1-2):99-106. PubMed ID: 9619864
[TBL] [Abstract][Full Text] [Related]
6. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
Hattori Y; Shi L; Ding W; Koga K; Kawano K; Hakoshima M; Maitani Y
J Control Release; 2009 May; 136(1):30-7. PubMed ID: 19331859
[TBL] [Abstract][Full Text] [Related]
7. Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.
Sadzuka Y; Hirotsu S; Hirota S
Jpn J Cancer Res; 1999 Feb; 90(2):226-32. PubMed ID: 10189894
[TBL] [Abstract][Full Text] [Related]
8. Liposome-loaded thermo-sensitive hydrogel for stabilization of SN-38 via intratumoral injection: optimization, characterization, and antitumor activity.
Bai R; Deng X; Wu Q; Cao X; Ye T; Wang S
Pharm Dev Technol; 2018 Jan; 23(1):106-115. PubMed ID: 29019266
[TBL] [Abstract][Full Text] [Related]
9. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y
J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties of irinotecan-containing nanoparticles prepared using poly(DL-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol).
Onishi H; Machida Y; Machida Y
Biol Pharm Bull; 2003 Jan; 26(1):116-9. PubMed ID: 12520188
[TBL] [Abstract][Full Text] [Related]
12. A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models.
Su Z; Li L; Hao F; Zhao J; Li M; Zhao X; Zhao D
Pharm Res; 2023 Dec; 40(12):3043-3058. PubMed ID: 37914843
[TBL] [Abstract][Full Text] [Related]
13. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
14. Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts.
Iwase Y; Maitani Y
Cancer Sci; 2012 Feb; 103(2):310-6. PubMed ID: 22017398
[TBL] [Abstract][Full Text] [Related]
15. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
[TBL] [Abstract][Full Text] [Related]
16. A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.
Huang Y; Yang T; Zhang W; Lu Y; Ye P; Yang G; Li B; Qi S; Liu Y; He X; Lee RJ; Xu C; Xiang G
Int J Nanomedicine; 2014; 9():4581-95. PubMed ID: 25302024
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex.
Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z
Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963
[TBL] [Abstract][Full Text] [Related]
18. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
Fang YP; Chuang CH; Wu YJ; Lin HC; Lu YC
Int J Nanomedicine; 2018; 13():2789-2802. PubMed ID: 29785106
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes.
Liu Y; Li X; Pen R; Zuo W; Chen Y; Sun X; Gou J; Guo Q; Wen M; Li W; Yu S; Liu H; Huang M
Biomed Eng Online; 2022 Aug; 21(1):53. PubMed ID: 35918704
[TBL] [Abstract][Full Text] [Related]
20. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]